Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StackerofWheat 

Vertex Pharmaceuticals Inc. diskutieren

Vertex Pharmaceuticals Inc.

WKN: 882807 / Symbol: VRTX / Name: Vertex / Aktie / Biotechnologie & medizinische Forschung / Large Cap /

419,45 €
0,44 %

Vertex Pharmaceuticals (VRTX) was upgraded by Wall Street Zen from "hold" to "buy".
Ratings data for VRTX provided by MarketBeat

Einschätzung Sell
Rendite (%) -9,60 %
Kursziel 306,01
Veränderung
Endet am 07.07.27

Vertex Pharmaceuticals (VRTX) had its price target raised by Robert W. Baird from $330.00 to $350.00. They now have an "underperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Vertex Pharmaceuticals (VRTX) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for VRTX provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,08 %
Kursziel 491,40
Veränderung
Endet am 13.07.27

Vertex Pharmaceuticals (VRTX) was given a new $560.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Vertex Pharmaceuticals (VRTX) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for VRTX provided by MarketBeat